Sulfoluciferin is Biosynthesized by a Specialized Luciferin Sulfotransferase in Fireflies

• Sulfoluciferin is a real metabolite, not an artifact. LC-HRAM-MS of P. pyralis lantern extracts detected luciferyl sulfate at substantial levels alongside free luciferin. This had been hypothesized off and on since the 1970s but never cleanly confirmed in vivo. The compound is real and abundant, which means any model of firefly luciferin metabolism has to account for a sulfated pool.
• A dedicated luciferin sulfotransferase (LST) catalyzes the reaction. The authors identified a lantern-enriched cytosolic sulfotransferase, expressed it recombinantly, and showed it sulfates D-luciferin using PAPS as the sulfate donor. The enzyme is specific, it doesn't act on generic phenolic substrates the way broad detoxification SULTs do. This is a specialized enzyme of bioluminescence metabolism, not a moonlighting xenobiotic enzyme.
• The proposed function is luciferin storage. Free luciferin is reactive and can be oxidized non-enzymatically; sulfoluciferin is stable and inert. Sulfation parks luciferin as a non-reactive pool that can be drawn down (via a hypothesized sulfatase) when light production is needed. This is a classic plant-biochemistry storage strategy, sulfation and glycosylation both serve to detoxify and warehouse reactive metabolites, and the parallel to arbutin storage of hydroquinone (Oba 2013) is striking.
• LST is firefly-specific. Direct orthologs are present in A. lateralis but absent in the bioluminescent click beetle I. luminosus (later confirmed in Fallon 2018). The sulfation-storage strategy is a Lampyrid trait, not an ancestral feature of beetle bioluminescence. Click beetles solve the storage problem differently, or don't store luciferin at the same scale.
• PAPS supply in the lantern is also dedicated. The combined adenylyl-sulfate kinase / sulfate adenylyltransferase (ASKSA) that produces PAPS is itself lantern-enriched and peroxisomally targeted in fireflies (Fallon 2018). The cofactor supply is built up alongside the enzyme, sulfation of luciferin is not a side reaction running on ambient PAPS, it's a provisioned pathway.

Bottom line for the project: Luciferin homeostasis in the firefly lantern is two-tiered, a free reactive pool used for light production and a sulfated stable pool held in reserve. For a heterologous N. tabacum system you almost certainly do not need an LST ortholog: tobacco lacks the firefly's flux problem, your luciferin titers will be limiting rather than excessive, and you don't want to siphon scarce product into an inert storage form. But the paper matters for two reasons. First, it sets a precedent that firefly luciferin metabolism is more elaborate than substrate → enzyme → light, which is worth flagging when you describe pathway scope in proposals. Second, if your stable-transformation lines (Phase 4) ever do produce too much luciferin and start showing toxicity or off-tissue glow, sulfation is one of the obvious mitigations to bolt on, plants already have endogenous SULTs and PAPS supply, so an LST or an LST-like activity could be co-expressed to buffer the pool. Worth keeping on the shelf, not in the current build.